Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes
<h4>Context</h4> <p>In the past few years, research has suggested that molecular subtypes in muscle-invasive bladder cancer (MIBC) may be exploited to accelerate developments in clinical disease management and novel therapeutics.</p> <h4>Objective</h4> <p>T...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|
| _version_ | 1797092416173375488 |
|---|---|
| author | Ruan, J Hsu, J Browning, R Stride, E Yildiz, Y Vojnovic, B Kiltie, A |
| author_facet | Ruan, J Hsu, J Browning, R Stride, E Yildiz, Y Vojnovic, B Kiltie, A |
| author_sort | Ruan, J |
| collection | OXFORD |
| description | <h4>Context</h4> <p>In the past few years, research has suggested that molecular subtypes in muscle-invasive bladder cancer (MIBC) may be exploited to accelerate developments in clinical disease management and novel therapeutics.</p> <h4>Objective</h4> <p>This review summarises the existing MIBC mouse models from a molecular subtype perspective, their advantages and limitations, and their applications in translational medicine, based on a Pubmed search for publications from January 2000 to February 2018. </p> <h4>Evidence Acquistion</h4> <p>Publications relevant to MIBC mouse models and their molecular subtypes were identified in a literature review.</p> <h4>Evidence Synthesis</h4> <p>We classified the models based on the technique used for their establishment. For xenotransplant and allograft models, the inoculated cells and inoculated locations are the major determinants of molecular subtypes. Although the cell lines used in the xenotransplant models can cover most of the basal-squamous and luminal subtypes, allograft models offer a more realistic environment in which to reconstruct aspects of the associated stromal and immune features. Autochthonous models, using genetic and/or chemical stimuli to induce disease progression, can also generate models with basal-squamous and luminal subtypes, but further molecular characterisation is needed since other mutational variants may be introduced in these models.</p> <h4>Conclusions</h4> <p>We have identified preclinical models with different subtype specifications and assessed their promise and current limitations. These models are versatile tools which can reproduce the molecular complexity of the disease and support novel therapeutic development.</p> |
| first_indexed | 2024-03-07T03:45:36Z |
| format | Journal article |
| id | oxford-uuid:bf5d1588-aebd-4af1-a95a-fff3ff284c67 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:45:36Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:bf5d1588-aebd-4af1-a95a-fff3ff284c672022-03-27T05:46:52ZMouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bf5d1588-aebd-4af1-a95a-fff3ff284c67Symplectic Elements at OxfordElsevier2018Ruan, JHsu, JBrowning, RStride, EYildiz, YVojnovic, BKiltie, A <h4>Context</h4> <p>In the past few years, research has suggested that molecular subtypes in muscle-invasive bladder cancer (MIBC) may be exploited to accelerate developments in clinical disease management and novel therapeutics.</p> <h4>Objective</h4> <p>This review summarises the existing MIBC mouse models from a molecular subtype perspective, their advantages and limitations, and their applications in translational medicine, based on a Pubmed search for publications from January 2000 to February 2018. </p> <h4>Evidence Acquistion</h4> <p>Publications relevant to MIBC mouse models and their molecular subtypes were identified in a literature review.</p> <h4>Evidence Synthesis</h4> <p>We classified the models based on the technique used for their establishment. For xenotransplant and allograft models, the inoculated cells and inoculated locations are the major determinants of molecular subtypes. Although the cell lines used in the xenotransplant models can cover most of the basal-squamous and luminal subtypes, allograft models offer a more realistic environment in which to reconstruct aspects of the associated stromal and immune features. Autochthonous models, using genetic and/or chemical stimuli to induce disease progression, can also generate models with basal-squamous and luminal subtypes, but further molecular characterisation is needed since other mutational variants may be introduced in these models.</p> <h4>Conclusions</h4> <p>We have identified preclinical models with different subtype specifications and assessed their promise and current limitations. These models are versatile tools which can reproduce the molecular complexity of the disease and support novel therapeutic development.</p> |
| spellingShingle | Ruan, J Hsu, J Browning, R Stride, E Yildiz, Y Vojnovic, B Kiltie, A Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title | Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title_full | Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title_fullStr | Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title_full_unstemmed | Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title_short | Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes |
| title_sort | mouse models of muscle invasive bladder cancer key considerations for clinical translation based on molecular subtypes |
| work_keys_str_mv | AT ruanj mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT hsuj mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT browningr mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT stridee mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT yildizy mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT vojnovicb mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes AT kiltiea mousemodelsofmuscleinvasivebladdercancerkeyconsiderationsforclinicaltranslationbasedonmolecularsubtypes |